These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 26843609

  • 1. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
    Hiniker A, Daniels BH, Margeta M.
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
    [Abstract] [Full Text] [Related]

  • 2. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A, Daniels BH, Lee HS, Margeta M.
    Acta Neuropathol Commun; 2013 Jul 01; 1():29. PubMed ID: 24252466
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and Clinical Development of Sporadic Inclusion Body Myositis and Polymyositis With Mitochondrial Pathology: A Single-Center Retrospective Analysis.
    Winkler M, von Landenberg C, Kappes-Horn K, Neudecker S, Kornblum C, Reimann J.
    J Neuropathol Exp Neurol; 2021 Nov 19; 80(11):1060–1067. PubMed ID: 34643702
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
    Choi YC, Dalakas MC.
    Neurology; 2000 Jan 11; 54(1):65-71. PubMed ID: 10636127
    [Abstract] [Full Text] [Related]

  • 6. Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis.
    Vogt S, Kleefeld F, Preusse C, Arendt G, Bieneck S, Brunn A, Deckert M, Englert B, Goebel HH, Masuhr A, Neuen-Jacob E, Kornblum C, Reimann J, Montagnese F, Schoser B, Stenzel W, Hahn K.
    J Neurol; 2023 Sep 11; 270(9):4434-4443. PubMed ID: 37280376
    [Abstract] [Full Text] [Related]

  • 7. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.
    Kleefeld F, Uruha A, Schänzer A, Nishimura A, Roos A, Schneider U, Goebel HH, Schuelke M, Hahn K, Preusse C, Stenzel W.
    Neurology; 2022 Nov 15; 99(20):e2212-e2222. PubMed ID: 36195449
    [Abstract] [Full Text] [Related]

  • 8. Inflammatory myopathies with mitochondrial pathology and protein aggregates.
    Temiz P, Weihl CC, Pestronk A.
    J Neurol Sci; 2009 Mar 15; 278(1-2):25-9. PubMed ID: 19101700
    [Abstract] [Full Text] [Related]

  • 9. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
    Papadimas GK, Kokkinis C, Xirou S, Chrysanthou M, Kararizou E, Papadopoulos C.
    Rheumatol Int; 2019 Aug 15; 39(8):1459-1466. PubMed ID: 31055642
    [Abstract] [Full Text] [Related]

  • 10. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
    Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L.
    Arthritis Rheum; 1997 May 15; 40(5):865-74. PubMed ID: 9153548
    [Abstract] [Full Text] [Related]

  • 11. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
    Zierer LK, Naegel S, Schneider I, Kendzierski T, Kleeberg K, Koelsch AK, Scholle L, Schaefer C, Naegel A, Zierz S, Otto M, Stoltenburg-Didinger G, Kraya T, Stoevesandt D, Mensch A.
    J Neurol; 2024 Jun 15; 271(6):3186-3202. PubMed ID: 38438820
    [Abstract] [Full Text] [Related]

  • 12. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
    Murata K, Dalakas MC.
    Am J Pathol; 1999 Aug 15; 155(2):453-60. PubMed ID: 10433938
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.
    Dion E, Cherin P, Payan C, Fournet JC, Papo T, Maisonobe T, Auberton E, Chosidow O, Godeau P, Piette JC, Herson S, Grenier P.
    J Rheumatol; 2002 Sep 15; 29(9):1897-906. PubMed ID: 12233884
    [Abstract] [Full Text] [Related]

  • 15. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N, Engel AG.
    Neurology; 2008 Feb 05; 70(6):418-24. PubMed ID: 17881720
    [Abstract] [Full Text] [Related]

  • 16. Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions.
    Molnar M, Schröder JM.
    Acta Neuropathol; 1998 Jul 05; 96(1):41-51. PubMed ID: 9678512
    [Abstract] [Full Text] [Related]

  • 17. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
    Yamashita S, Kimura E, Tawara N, Sakaguchi H, Nakama T, Maeda Y, Hirano T, Uchino M, Ando Y.
    Neuropathol Appl Neurobiol; 2013 Jun 05; 39(4):406-16. PubMed ID: 22860700
    [Abstract] [Full Text] [Related]

  • 18. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
    De Paepe B, Creus KK, Martin JJ, Weis J, De Bleecker JL.
    Ann N Y Acad Sci; 2009 Sep 05; 1173():463-9. PubMed ID: 19758187
    [Abstract] [Full Text] [Related]

  • 19. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
    Morosetti R, Gliubizzi C, Sancricca C, Broccolini A, Gidaro T, Lucchini M, Mirabella M.
    Am J Pathol; 2012 Apr 05; 180(4):1603-13. PubMed ID: 22314077
    [Abstract] [Full Text] [Related]

  • 20. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
    Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Vianna MA, Sachetti S, Marie SK.
    Autoimmun Rev; 2006 Feb 05; 5(2):93-100. PubMed ID: 16431335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.